Pancreas-targeted lipid nanoparticles for relatively non-invasive interleukin-12 mRNA therapy in orthotopic pancreatic ductal adenocarcinoma
Authors:
- Jia LiuJLJia Liu
- Lingyun WangLWLingyun Wang
- Xiaoding XuXXXiaoding Xu
- 1 March 2025
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 381, 113588
Abstract
No abstract availableKeywords
Funding Information
- Fundamental Research Funds for the Central Universities (22hytd12)
- National Natural Science Foundation of China (52473328)
- Guangzhou Municipal Science and Technology Bureau (2024A03J0846)
- Guangzhou Municipal Science and Technology Bureau (2024A04J6561)
This publication has 36 references indexed in Scilit:
- Immunologic tumor microenvironment modulators for turning cold tumors hotCancer Communications, 2024
- From structural design to delivery: mRNA therapeutics for cancer immunotherapyExploration, 2023
- Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer TherapyAdvanced Materials, 2023
- Pancreatic cancer: Advances and challengesCell, 2023
- The role of lipid components in lipid nanoparticles for vaccines and gene therapyAdvanced Drug Delivery Reviews, 2022
- Ipilimumab/Nivolumab Therapy in Patients With Metastatic Pancreatic or Biliary Cancer With Homologous Recombination Deficiency Pathogenic Germline VariantsJAMA Oncology, 2022
- Polymeric and lipid nanoparticles for delivery of self-amplifying RNA vaccinesJournal of Controlled Release, 2021
- Next‐Generation Vaccines: Nanoparticle‐Mediated DNA and mRNA DeliveryAdvanced Healthcare Materials, 2021
- Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**Angewandte Chemie International Edition, 2012
- Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acidsJournal of Controlled Release, 2005